Form 4: Kimberly-Clark Executive Gonzalo Uribe Reports Stock Sale
SEC Form 4 Filing
Gonzalo Uribe, President of Latin America at Kimberly-Clark, reported the sale of 1,780 shares of common stock on July 29, 2024.
Summary
- Gonzalo Uribe, President, Latin America at Kimberly-Clark Corp, filed a Form 4 with the SEC on July 29, 2024.
- The filing reports a transaction where Uribe sold 1,780 shares of Kimberly-Clark common stock at a price of $140.84 per share.
- Following the transaction, Uribe directly owns 7,377 shares of Kimberly-Clark common stock.
- The filing also includes a Substitute Power of Attorney, appointing Courtney Roane as a substitute attorney-in-fact on behalf of several individuals, including Gonzalo Uribe, to execute and file documents with the SEC.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing reporting a stock sale by an executive. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about the transaction.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. Investors often monitor these filings to gain insights into management's perspective on the company's stock.
Comparison to Industry Standards
- Comparing Gonzalo Uribe's transactions to those of other executives at peer companies like Procter & Gamble (PG) or Unilever (UL) could provide context on whether this sale is typical or unusual.
- Reviewing similar Form 4 filings from executives at these companies can help determine if the transaction size and frequency are in line with industry norms.
- Benchmarking the timing of the sale against Kimberly-Clark's recent performance and upcoming catalysts (e.g., earnings releases, product launches) can offer further insights.
Stakeholder Impact
- The stock sale by a company executive could be perceived negatively by shareholders if they interpret it as a lack of confidence in the company's future performance.
- However, such transactions are common and may not necessarily indicate a negative outlook.
Key Dates
| Date | Description |
|---|---|
| November 15, 2015 | Michael D. Hsu Power of Attorney date |
| June 15, 2016 | Christa S. Quarles Power of Attorney date |
| July 19, 2017 | Jeffrey P. Melucci Power of Attorney date |
| September 12, 2018 | Sherilyn S. McCoy Power of Attorney date |
| March 1, 2019 | Andrew S. Drexler Power of Attorney date |
| July 29, 2019 | Alison Lewis Power of Attorney date |
| May 2, 2019 | S. Todd Maclin Power of Attorney date |
| May 1, 2019 | Dunia A. Shive Power of Attorney date |
| September 19, 2019 | Mark T. Smucker Power of Attorney date |
| August 13, 2020 | John W. Culver Power of Attorney date |
| October 12, 2020 | Sandra R. Karrmann Power of Attorney date |
| October 26, 2020 | Gonzalo Uribe Power of Attorney date |
| February 18, 2020 | Russell Torres Power of Attorney date |
| March 15, 2021 | Robert E. Long Power of Attorney date |
| September 14, 2021 | Doug Cunningham Power of Attorney date |
| September 1, 2021 | Deirdre A. Mahlan Power of Attorney date |
| September 1, 2021 | Jaime A. Ramirez Power of Attorney date |
| January 3, 2022 | Ehab Abou-Oaf Power of Attorney date |
| March 17, 2022 | Sylvia M. Burwell Power of Attorney date |
| March 29, 2022 | Nelson Urdaneta Power of Attorney date |
| July 11, 2022 | Zackery A. Hicks Power of Attorney date |
| September 9, 2022 | Tamera Fenske Power of Attorney date |
| August 27, 2023 | Deeptha Khanna Power of Attorney date |
| February 1, 2024 | Grant B. McGee Power of Attorney date |
| July 22, 2024 | Effective date of Substitute Power of Attorney |
| July 29, 2024 | Date of stock sale transaction |
| July 29, 2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.